GSK stock jumped Wednesday after the British drugmaker said it's "well positioned" to respond if the U.S. levies tariffs on drug imports.
The post GSK Jumps On Solid Earnings, Says It's 'Well Positioned' To Navigate Tariffs appeared first on Investor's Business Daily.